GLP-1 Agonists First on the list is the GLP-1 agonists
Although they are marketed as next-generation biohacks and research chemicals, many peptides are not approved for human use and lack basic clinical testing
Early data shows improvements in cardiovascular risk markers (cholesterol, blood pressure, inflammation), but these are surrogate endpoints, not proven event reduction
Pain or Discomfort at the Injection Site: Some people may experience temporary pain, redness, or swelling at the injection site
Small working aliquots in polypropylene tubes can be made after reconstitution and store the vials at -20C or lower
Digital weight loss company Noom has entered the evolving GLP-1 medication landscape with the launch of its Noom Microdose GLP-1Rx Program, offering members personalized microdoses of GLP-1 medications combined with behavioral coaching and clinical support